Liven Pharma Limited (PSX:LIVEN)
Pakistan flag Pakistan · Delayed Price · Currency is PKR
31.47
-1.43 (-4.35%)
At close: Nov 6, 2026

Liven Pharma Financials Overview

Millions PKR. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
111.28105.81127.27245.09--
Revenue Growth
135.85%-16.87%-48.07%---
Gross Profit
-17.23-10.7315.8262.14--
Operating Income
-61.72-75.93-491.7141.77-15.22-17.51
Net Income
-8.35-31.14-584.4641.74-12.33-14.29
Earnings Per Share
-0.08-0.28-7.111043.60-1.02-1.18
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
176.79181.557.8824.960.030.03
Total Debt
33.133.4434.67156.91237.62235.35
Net Cash (Debt)
143.69148.11-26.78-131.95-237.59-235.32
Net Cash Growth
------
Net Cash Per Share
1.291.33-0.33-3298.85-19.60-19.41

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
10.368.99-1.7213.8-2.27-2.26
Capital Expenditures
-29.44-29.66-22.84---
Free Cash Flow
-19.08-20.68-24.5613.8-2.27-2.26
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
-15.48%-10.14%12.43%25.35%--
Operating Margin
-55.46%-71.76%-386.34%17.04%--
Pretax Margin
-39.97%-62.68%-386.72%17.03%--
Profit Margin
-7.51%-29.43%-459.22%17.03%--
FCF Margin
-17.14%-19.54%-19.30%5.63%--

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PE Ratio
---2.65--
P/FCF Ratio
---8.00--
PS Ratio
31.9743.5047.470.45--